Xiaoran Li
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Health Informatics top 5%
Papers in
-
- Cancer, Hypoxia, and Metabolism 12
- Co-authors
- Zhenhe SuoJahn M. NeslandJustin LipnerJingwei XieYounan XiaCionne N. ManningStavros ThomopoulosYaqing Li
- Journals
- Oncotarget (8 papers)Scientific Reports (4 papers)BMC Cancer (3 papers)Frontiers in Immunology (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xiaoran Li
94 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 142
- Cancer Research 409
- Health Informatics 26
- Biomaterials 202
- Orthopedics and Sports Medicine 92
- Oncology 264
Countries citing papers authored by Xiaoran Li
This map shows the geographic impact of Xiaoran Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoran Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoran Li more than expected).
Fields of papers citing papers by Xiaoran Li
This network shows the impact of papers produced by Xiaoran Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoran Li. The network helps show where Xiaoran Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoran Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 22 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 74 | |
| 15 | 2020 | 3 | |
| 16 | 2017 | 64 | |
| 17 | 2016 | 27 | |
| 18 | 2016 | 6 | |
| 19 | 2015 | 28 | |
| 20 | 2013 | 3 |
About Xiaoran Li
Xiaoran Li is a scholar working on Cancer Research, Microbiology, Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 105 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), Mitochondrial Function and Pathology (10 papers), Radiomics and Machine Learning in Medical Imaging (9 papers), Endometrial and Cervical Cancer Treatments (7 papers), Cancer Cells and Metastasis (6 papers), Bladder and Urothelial Cancer Treatments (6 papers), Epigenetics and DNA Methylation (6 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Cancer Research (409 citations), Health Informatics (26 citations), Biomaterials (202 citations), Orthopedics and Sports Medicine (92 citations) and Oncology (264 citations). Xiaoran Li has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Zhenhe Suo, Jahn M. Nesland, Justin Lipner, Jingwei Xie, Younan Xia, Cionne N. Manning, Stavros Thomopoulos, Yaqing Li, Jie Sun and Mingzhi Zhang. Their work appears in journals such as Oncotarget, Scientific Reports, BMC Cancer, Frontiers in Immunology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.